Development of a Sensitive Chemiluminescent Neuraminidase Assay for the Determination of Influenza Virus Susceptibility to Zanamivir
- 1 May 2000
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 280 (2) , 291-300
- https://doi.org/10.1006/abio.2000.4517
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Zanamivir Susceptibility Monitoring and Characterization of Influenza Virus Clinical Isolates Obtained during Phase II Clinical Efficacy StudiesAntimicrobial Agents and Chemotherapy, 2000
- Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B VirusThe Journal of Infectious Diseases, 1998
- Generation and Characterization of an Influenza Virus Neuraminidase Variant with Decreased Sensitivity to the Neuraminidase-Specific Inhibitor 4-Guanidino-Neu5Ac2enVirology, 1995
- Molecular Basis for the Resistance of Influenza Viruses to 4-Guanidino-Neu5Ac2enVirology, 1995
- 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitroAntimicrobial Agents and Chemotherapy, 1993
- Chemiluminescence lights upNature, 1989
- Plaque inhibition assay for drug susceptibility testing of influenza virusesAntimicrobial Agents and Chemotherapy, 1980
- Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-d-N-acetylneuraminate) substrateAnalytical Biochemistry, 1979
- Characterization of temperature sensitive influenza virus mutants defective in neuraminidaseVirology, 1974
- Synthese anomerer Sialinsäure‐methylketosideEuropean Journal of Inorganic Chemistry, 1966